Logo image of CVS.DE

CVS HEALTH CORP (CVS.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:CVS - US1266501006 - Common Stock

66.49 EUR
-0.35 (-0.52%)
Last: 12/23/2025, 7:00:00 PM

CVS.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap84.40B
Revenue(TTM)394.08B
Net Income(TTM)469.00M
Shares1.27B
Float1.26B
52 Week High73.65
52 Week Low42.45
Yearly Dividend2.25
Dividend Yield3.36%
EPS(TTM)5.81
PE11.44
Fwd PE10.82
Earnings (Next)02-10 2026-02-10/amc
IPO1952-10-01
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Services


CVS.DE short term performance overview.The bars show the price performance of CVS.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10

CVS.DE long term performance overview.The bars show the price performance of CVS.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 0 20 -20 40

The current stock price of CVS.DE is 66.49 EUR. In the past month the price decreased by -2.19%. In the past year, price increased by 55.28%.

CVS HEALTH CORP / CVS Daily stock chart

CVS.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Services" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
FRE.DE FRESENIUS SE & CO KGAA 14.21 27.29B
FME.DE FRESENIUS MEDICAL CARE AG 10.84 23.91B
V3V.DE FAMICORD AG 43.57 107.60M
HI.MI HEALTH ITALIA SPA 18.2 56.05M

About CVS.DE

Company Profile

CVS logo image CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. The company is headquartered in Woonsocket, Rhode Island and currently employs 300,000 full-time employees. The firm's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.

Company Info

CVS HEALTH CORP

One Cvs Dr.

Woonsocket RHODE ISLAND US

Employees: 259500

CVS Company Website

CVS Investor Relations

Phone: 14017651500

CVS HEALTH CORP / CVS.DE FAQ

What does CVS do?

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. The company is headquartered in Woonsocket, Rhode Island and currently employs 300,000 full-time employees. The firm's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, diagnostic testing and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.


What is the current price of CVS stock?

The current stock price of CVS.DE is 66.49 EUR. The price decreased by -0.52% in the last trading session.


Does CVS stock pay dividends?

CVS HEALTH CORP (CVS.DE) has a dividend yield of 3.36%. The yearly dividend amount is currently 2.25.


How is the ChartMill rating for CVS HEALTH CORP?

CVS.DE has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 4 out of 10.


What do analysts say about CVS HEALTH CORP (CVS.DE) stock?

33 analysts have analysed CVS.DE and the average price target is 82.37 EUR. This implies a price increase of 23.88% is expected in the next year compared to the current price of 66.49.


What is the market capitalization of CVS stock?

CVS HEALTH CORP (CVS.DE) has a market capitalization of 84.40B EUR. This makes CVS.DE a Large Cap stock.


Who owns CVS HEALTH CORP?

You can find the ownership structure of CVS HEALTH CORP (CVS.DE) on the Ownership tab.


CVS.DE Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to CVS.DE. When comparing the yearly performance of all stocks, CVS.DE is one of the better performing stocks in the market, outperforming 91.34% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

CVS.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 4 / 10 to CVS.DE. Both the profitability and financial health of CVS.DE have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CVS.DE Financial Highlights

Over the last trailing twelve months CVS.DE reported a non-GAAP Earnings per Share(EPS) of 5.81. The EPS increased by 7.87% compared to the year before.


Industry RankSector Rank
PM (TTM) 0.12%
ROA 0.18%
ROE 0.64%
Debt/Equity 0.85
Chartmill High Growth Momentum
EPS Q2Q%46.79%
Sales Q2Q%7.8%
EPS 1Y (TTM)7.87%
Revenue 1Y (TTM)6.82%

CVS.DE Forecast & Estimates

33 analysts have analysed CVS.DE and the average price target is 82.37 EUR. This implies a price increase of 23.88% is expected in the next year compared to the current price of 66.49.

For the next year, analysts expect an EPS growth of 23.97% and a revenue growth 7.57% for CVS.DE


Analysts
Analysts80.61
Price Target82.37 (23.88%)
EPS Next Y23.97%
Revenue Next Year7.57%

CVS.DE Ownership

Ownership
Inst Owners89.68%
Ins Owners0.99%
Short Float %N/A
Short RatioN/A